Hookipa Pharma

Hookipa Pharma is a biotechnology company that develops and commercializes immunotherapeutics for the treatment of infectious diseases and cancer.

Business Model:

Revenue: $10.3M

Employees: 51-200

Detailed Hookipa Pharma Information

Geographic Data

Hookipa Pharma headquarters map

Address: 350 Fifth Avenue

City: New York

State: NY

Zip: 10118

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$75M

Raised Total:

$224M

Metrics

6,737,408Website Global Rank

739Website Monthly Traffic

Twitter Followers

Description

Hookipa Pharma is a biotechnology company that develops and commercializes immunotherapeutics for the treatment of infectious diseases and cancer.

Contact Phone:
+14318906360

Contact Email:

Hookipa Pharma went public on 4/17/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
4/17/2019

IPO Valuation:
$302M

Ticker Symbol:
HOOK

IPO Price:
$14/share

Amount Raised:
$84M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2017 Series C $59.6M HBM Partners
Sirona Capital
12/2016 Series B 5 $10.7M Takeda Ventures
Sofinnova Partners
Forbion Capital Partners
Boehringer Ingelheim Venture Fund
BioMedPartners
10/2016 Grant 1 $4.6M The Austrian Research Promotion Agency (FFG)
The Austrian Research Promotion Agency (FFG)
2/2019 Series D 5 $37.4M Baker Brothers Advisors LLC
Samsara BioCapital
Redmile Group
Takeda Ventures
Invus
Redmile Group
Baker Brothers Advisors LLC
Samsara BioCapital
Redmile Group
Takeda Ventures
Invus
Redmile Group
11/2013 Series B 5 $27M Forbion Capital Partners
Sofinnova Partners
Takeda Ventures
Boehringer Ingelheim Venture Fund
BioMedPartners
Forbion Capital Partners
Sofinnova Partners
12/2017 Series C $0 Hillhouse Capital Group
Takeda Ventures
Sofinnova Partners
BioMedPartners
Sirona Capital
Baker Brothers Advisors LLC
Boehringer Ingelheim Venture Fund
Forbion Capital Partners
Gilead Group
HBM Partners
Hillhouse Capital Group
Takeda Ventures
Sofinnova Partners
BioMedPartners
Sirona Capital
Baker Brothers Advisors LLC
Boehringer Ingelheim Venture Fund
Forbion Capital Partners
Gilead Group
HBM Partners
3/2022 Post-IPO Equity $75M
12/2020 Post-IPO Equity $80.9M
4/2019 IPO $84M
10/2011 Series A 2 $9.6M Sofinnova Partners
Forbion Capital Partners
Sofinnova Partners
12/2017 Series C 10 $60M Hillhouse Capital Group
Takeda Ventures
Sofinnova Partners
BioMedPartners
Sirona Capital
Baker Brothers Advisors LLC
Hillhouse Capital Group
Takeda Ventures
Sofinnova Partners
BioMedPartners
Sirona Capital
Baker Brothers Advisors LLC
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research